Organic dust induced pulmonary disease - The role of mould derived B-Glucan

Annals of Agricultural and Environmental Medicine

Volumn 17, Issue 1, 2010, Pages 9-13

  Rylander, Ragnar ^a  

^a BioFact Environmental Health Research Center   (Sweden)

Author keywords

glucan; Endotoxin; Inflammation; Inhalation; Mould

Indexed keywords

BETA GLUCAN; CYTOKINE;

ALLERGIC PNEUMONITIS; ATOPY; CELL AGGREGATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; LUNG DISEASE; MOULD; NEUTROPHIL; NONHUMAN; ORGANIC DUST; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; BETA-GLUCANS; DUST; FUNGI; HUMANS; LUNG DISEASES;

EID: 77955154053     PISSN: 12321966     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Beijer L, Thorn J, Rylander R: Effects after inhalation of (1→3)- β-D-glucan and relation to mould exposure in the home. Mediators Inflamm 2002, 11(3), 149-153.
2. Beijer L, Thorn J, Rylander R: Mould exposure at home relates to inflammatory markers in blood. Eur Respir J 2003, 21, 317-322.
3. Beijer L, Rylander R: (1 →3)-β-D-Glucan does not induce acute inflammation after nasal deposition. Mediators Infamm 2005, 1 (2205), 50-52.
4. Blackley CH: Experimental Researches on the Causes and Nature of Catarrhus Aestivus (Hay-Fever or Hay-Asthma). Oxford Historical Books, Abingdon 1988 (first published by Ballière-Tindall and Cox, London 1873).
5. Douwes J, Doekes G, Montijn R, Heederik D, Brunekreef B: Measurement of β(1-3)-glucans in occupational and home environments with inhibition enzyme immunoassay. Appl Env Microbiol 1996, 62, 3176-3182.
6. Fisk WJ, Lei-Gomez Q, Mendell MJ: Meta-analysis of the associations of respiratory health effects with dampness and molds in homes. Indoor Air 2007, 17, 284-296.
7. Fogelmark B, Sjöstrand M, Rylander R: Pulmonary inflammation induced by repeated inhalations of β-1,3-glucan and endotoxin. Int J Exp Path 1974, 75, 85-90.
8. Fogelmark B, Goto H, Yuasa K, Marchat B, Rylander R: Acute pulmonary toxicity of inhaled β,1,3-glucan and endotoxin. Agents Actions 1992, 35, 50-55.
9. Fogelmark B, Thorn J, Rylander R: Inhalation of (1-3)-β-D-glucan causes airway eosinophilia. Mediators Infl 2001, 10, 13-19.
10. Goodridge HS, Wolf AJ, Underhill DM: β-glucan recognition by the innate immune system. Immunol Rev 2009, 230, 38-50.
11. Inoue K, Takano H, Oda T, Yanagisawa R, Tamura H, Ohno N, Adachi Y, Ishibashi K, Yoshikawa T: Candida soluble cell wall β-D-glucan induces lung inflammation in mice. Int J Immunopath Pharmacol 2007, 20, 499-508.
12. Inoue K, Koike R, Yanagisawa R, Adachi Y, Ishibashi K, Ohno N, Takano H: Pulmonary exposure to soluble cell wall β-(1,3)-glucan of Aspergillus induces proinflammatory response in mice. Int J Immunopath Pharmacol 2009, 22, 2872-2897.
13. Inoue K, Takano H, Koike E, Yanagisawa R, Oda T, Tamura H, Adachi Y, Ishibashi K, Ohno N: Candida soluble cell wall β-glucan fraction facilitates ovalbumin-induced allergic airway inflammation in mice: possible role of antigen-presenting cells. Resp Res 2009, 10, 68-80.
14. Iossifova YY, Reponen T, Bernstein DI, Levin L, Kalra H, Campo P, Villareal M, Lockey J, Hershey GKK, LeMasters G: House dust (1-3)- β-D-glucan and wheezing in infants. Allergy 2007, 62, 504-513.
15. Korpi A, Kasanen J-P, Kosma V-M, Rylander R, Pasanen A-L: Slight respiratory irritation but not inflammation in mice exposed to (1 → 3)-ß-D-Glucan aerosols. Mediators Infl 2003, 12, 139-146.
16. Novak M, Vetvicka V: β-glucans, history, and the present: Immunomodulatory aspects and mechanisms of action. J Immunotoxicology 2008, 5, 47-57.
17. Pettigrew MM, Gent JF, Triche EW, Belanger KD, Bracken MB, Leaderer BP: Association of early-onset otitis media in infants and exposure to household mold. Pediat Perinatal Epidemiol 2004, 18, 441-447.
18. Rylander R, Jacobs RR (Eds): Organic Dusts - Exposure, Effects And Prevention. Lewis Publ, Boca Raton FA, USA, 1994, 1-298.
19. Rylander R: Endotoxin and occupational airway disease. Curr Opinions Allergy Clin Immunol 2006, 6, 62-66.
20. Rylander R: Endotoxin in the air - good or bad for you? Clinical Pulmonary Med 2007, 14, 140-147.
21. Rylander R: Evaluation of the risks of endotoxin exposure. Int J Occup Env Health 1997, 3, S32-S36.
22. Rylander R, Norrhall M, Engdahl U, Tunsäter A, Holt PG: Airways inflammation, atopy, and (1→3)-β-D-glucan exposures in two schools. Am J Respir Crit Care Med 1998, 158, 1685-1687.
23. Rylander R, Fogelmark B, Ewaldsson B: Mouldy environments and toxic pneumonitis. J Toxicol Ind Health 2008, 24, 177-180.
24. Rylander R, Holt PG: (1→3)-ß-D-glucan and endotoxin modulate immune response to inhaled allergen. Mediators Infl 1998, 7, 105-110.
25. Rylander R: Airway responsiveness and chest symptoms after inhalation of endotoxin and (1→3)-ß-D-glucan. Indoor Built Environ 1996, 5, 106-111.
26. Seung-Hyun C, Reponen T, LeMasters G, Levin L, Huang J, Meklin T, Villareal M, Bernstein D: Mold damage in homes and wheezing in infants. Ann Allergy Asthma Immunol 2006, 27, 1-7.
27. Soltys J, Quinn MT: Modulation of endotoxin- and enterotoxin-induced cytokine release by in vitro treatment with β-(1,6)-branched β-(1,3) glucan. Inf Immun 1999, 67, 244-252.
28. Stark PC, Celedón JC, Chew GL, Ryan LM, Burge HA, Muilenberg ML, Gold DR: Fungal levels in the home and allergic rhinitis by 5 years of age. Env Health Persp 2005, 113, 1405-1409.
29. Thorn J, Beijer L, Rylander R: Airways inflammation and glucan exposure among household waste collectors. Am J Ind Med 1998, 33, 463-470.
30. Thorn J, Beijer L, Rylander R: Effects after inhalation of (1→3)-ß-D-Glucan in healthy humans. Mediators Infl 2001, 10, 173-178.
31. Thorne PS, Kulhankova K, Yin M, Cohn R, Arbes Jr SJ, Zeldin DC: Endotoxin exposure as a risk factor for asthma: the national survey of endotoxin in US housing. Am J Resp Crit Care Med 2005, 172, 1371-1377.
32. Tsoni SV, Brown GD: B-glucans and dectin-1. Ann N Y Acad Sci 2008, 1143, 45-60.
33. Wan G-H, Li C-S, Guo S-P, Rylander R, Lin R-H: An airborne mold-derived product, (1-3)-ß-D-glucan, potentiates airway allergic responeses. Eur J Immunol 1999, 29, 2491-2497.
34. Young S-H, Castranova V (Eds): Toxicology of B-1,3-glucans, Glucans as a Marker for Fungal Exposure, 1-217. CRC Press 2005.
35. Young S-H, Ostroff G, Zeidler-Erdely PC, Roberts JR, Antonini JM, Castranova V: A comparison of the pulmonary inflammation potential of different components of yeast cell wall. J Toxicol Env Health 2007, 70, 1116-1124.
36. Young S-H, Robinson VA, Barger M, Porter DW, Frazer DG, Castranova V: Acute inflammation and recovery in rats after intratracheal instillation of a 1-3-β-glucan (zymosan A). J Toxicol Env Health 2001, 64, 311-325.
37. Young S-H, Robinson VA, Barger M, Zeidler P, Porter DW, Frazer DG, Castranova V: Modified endotoxin response in rats pretreated with 1-3-β-glucan (zymosan A). Toxicol Appl Pharmacol 2002, 178, 172-179.
38. Young S-H, Robinson VA, Barger M, Whitmer M, Porter DW, Frazer DG, Castranova V: Exposure to particulate 1-3-β-glucans induces greater pulmonary toxicity than soluble 1-3-β-glucans in rats. J Toxicol Env Health 2003, 66, 25-38.
39. Young S-H, Roberts JR, Antonini JM: Pulmonary exposure to 1-3-β-glucan alters adaptive immune responses in rats. Inhal Toxicol 2006, 18, 865-874.
40. Young S-H, Antonini JM, Roberts JR: Single pre-exposure to a high dose of zymosan enhances lung defence mechanisms and accelerates the pulmonary clearance of bacterial pathogens in rats. Exp Lung Res 2008, 34, 559-578.
41. Young S-H, Antonini JM, Roberts JR: Pre-exposure to repeated low doses of zymosan increases the susceptibility to pulmonary infection in rats. Exp Lung Res 2009, 35, 570-590.
42. Zielińska-Jankiewicz K, Kozajda A, Piotrowska M, Szadkowska-Stańczyk I: Microbiological contamination with moulds in work environment in libraries and archive storage facilities. Ann Agric Environ Med 2008, 15, 71-78.